ALECTOR INC

NASDAQ: ALEC (Alector, Inc.)

Last update: 28 Apr, 2:44PM

1.16

0.02 (1.75%)

Previous Close 1.14
Open 1.15
Volume 433,642
Avg. Volume (3M) 703,334
Market Cap 118,973,080
Price / Sales 1.71
Price / Book 1.63
52 Weeks Range
0.870 (-24%) — 6.78 (484%)
Earnings Date 6 May 2025 - 12 May 2025
Profit Margin -139.74%
Operating Margin (TTM) -1,216.52%
Diluted EPS (TTM) -1.26
Quarterly Revenue Growth (YOY) -76.90%
Total Debt/Equity (MRQ) 43.39%
Current Ratio (MRQ) 3.34
Operating Cash Flow (TTM) -229.34 M
Levered Free Cash Flow (TTM) -92.86 M
Return on Assets (TTM) -17.22%
Return on Equity (TTM) -90.26%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Bearish Bearish
Biotechnology (Global) Bearish Bearish
Stock Alector, Inc. Bullish Bearish

AIStockmoo Score

1.3
Analyst Consensus 3.5
Insider Activity 3.0
Price Volatility 0.5
Technical Moving Averages -2.5
Technical Oscillators 2.0
Average 1.30

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ALEC 119 M - - 1.63
CGON 2 B - - 2.91
ORIC 786 M - - 3.65
PHAT 733 M - - -
SANA 589 M - - 2.82
ZVRA 496 M - - 12.17

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 9.79%
% Held by Institutions 80.82%

Ownership

Name Date Shares Held
Euclidean Capital Llc 31 Dec 2024 1,307,858
52 Weeks Range
0.870 (-24%) — 6.78 (484%)
Median 10.00 (762.07%)
Total 1 Buy
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 09 May 2025 10.00 (762.07%) Buy 1.17
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
ALTMEYER MARK 1.63 - 28,700 46,781
DESOUZA ERROL B 1.63 - 28,700 46,781
GAROFALO ELIZABETH A. 1.63 - 28,700 46,781
HAMMOND PAULA 1.63 - 28,700 46,781
LAVIGNE LOUIS J JR 1.63 - 28,700 46,781
SCHELLER RICHARD H 1.63 - 28,700 46,781
YAFFE KRISTINE 1.63 - 28,700 46,781
Aggregate Net Quantity 200,900
Aggregate Net Value ($) 327,467
Aggregate Avg. Buy ($) 1.63
Aggregate Avg. Sell ($) -
Name Holder Date Type Quantity Price Value ($)
LAVIGNE LOUIS J JR Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781
DESOUZA ERROL B Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781
SCHELLER RICHARD H Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781
ALTMEYER MARK Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781
GAROFALO ELIZABETH A. Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781
HAMMOND PAULA Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781
YAFFE KRISTINE Director 11 Jun 2025 Acquired (+) 28,700 1.63 46,781

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria